Research graph
References from Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practice. Local targets link to admitted publications; unresolved targets remain external evidence.
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer
10.1016/s0022-5347(05)65855-7 · 2001 · External reference
Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer
10.1016/j.ijrobp.2007.01.043 · 2007 · External reference
Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes
10.1016/j.ijrobp.2007.11.066 · 2008 · External reference
Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer
10.1016/j.ijrobp.2012.05.023 · 2013 · External reference
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer
10.1016/j.ijrobp.2007.11.044 · 2008 · External reference
Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer
10.1016/j.ijrobp.2010.02.040 · 2011 · External reference
Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer
10.1016/j.ijrobp.2013.10.042 · 2014 · External reference
Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 Prostate Cancer Trial
10.1016/j.ijrobp.2013.07.041 · 2013 · External reference
Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant androgen deprivation therapy under an early salvage policy for patients with T3-T4N0M0 prostate cancer
10.1007/s10147-015-0867-7 · 2015 · External reference
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
10.1001/jama.280.11.969 · 1998 · External reference
Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol
10.1007/s10147-011-0324-1 · 2012 · External reference
Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer
10.1016/j.radonc.2009.03.013 · 2009 · External reference
Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer
10.1002/cncr.25467 · 2011 · External reference
Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68Gy to 78Gy
10.1016/j.ijrobp.2004.07.715 · 2005 · External reference
Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose–volume analysis of a phase II dose-escalation study
10.1016/j.ijrobp.2007.04.076 · 2007 · External reference
Ultra-high dose (86.4Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes
10.1016/j.ijrobp.2007.10.004 · 2008 · External reference
Hardware-sensitive optimization for intensity modulated radiotherapy
10.1088/0031-9155/45/2/312 · 2000 · External reference
Speed and convergence properties of gradient algorithms for optimization of IMRT
10.1118/1.1688214 · 2004 · External reference
Biological optimization of simultaneous boost on intra-prostatic lesions (DILs): sensitivity to TCP parameters
10.1016/j.ejmp.2012.10.002 · 2013 · External reference
Stereotactic body radiation therapy for prostate cancer: review of experience of a multicenter phase I/II dose-escalation study
10.3389/fonc.2014.00319 · 2014 · External reference
Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer
10.1016/j.ijrobp.2011.11.047 · 2012 · External reference
